M
en have an earlier onset and higher incidence of atherosclerosis than women. 1 The potential protective effects of estrogens on vascular structure and function have been studied extensively. Much less work, however, has addressed the possible effects of androgens on atherogenesis. In animal models, androgen treatment may increase plaque formation in the aorta and coronary vessels. 2, 3 Furthermore, in humans, we have recently demonstrated that androgens enhance monocyte adhesion to endothelial cells 4 and are associated with impaired vascular reactivity. 5 Foam cell formation is a key early event in atherosclerosis and is largely due to the uptake of modified lipoproteins, principally LDL, by peripheral blood monocyte-derived macrophages (MDMs) in the arterial wall. 6, 7 The possibility that androgen receptors (ARs) and androgen-related intracellular pathways may be involved in the process of lipid loading and foam cell formation in atherosclerosis has not been explored previously. We therefore investigated whether the AR is expressed in primary human MDMs and whether there is a sex difference in its expression and have examined the biological effects of androgen stimulation on cholesteryl ester (CE) formation/lipid loading in these cells.
Methods

Isolation of Human Monocytes
White cell concentrates (Red Cross Blood Bank) were obtained from the peripheral blood of individual healthy men (20 to 58 years old) and premenopausal (18 to 45 years old) and postmenopausal (45, 55, and 72 years old) women. The postmenopausal women all had had no menstruation for Ͼ3 years and had follicle-stimulating hormone levels Ͼ40 U/L. Monocytes were removed by density gradient separation and counterflow centrifugation elutriation. 8 Monocyte purity was Ͼ90% and viability Ͼ95% (trypan blue) in all experiments.
Culture and Analysis of Human MDMs
Monocytes isolated by elutriation were resuspended in phenol red-free RPMI (Life Technology) and allowed to adhere for Ն1.5 hours at 37°C under 5% CO 2 in air. Thereafter, phenol red-free RPMI containing 10% postmenopausal female human serum (17␤-estradiol Ͻ75 pmol/L, progesterone Ͻ0.8 nmol/L, and testosterone Ͻ2 nmol/L), penicillin G (50 U/mL), and streptomycin (50 g/mL) was added. Changes of medium occurred every 2 to 3 days, and hormone treatments (dihydrotestosterone, DHT, Sigma, at 4 to 400 nmol/L with or without the AR antagonist hydroxyflutamide, HF, 400 nmol/L) were added from days 3 through 10 with each change of medium. In the control conditions, no DHT or HF was added. Serum testosterone levels in healthy men range from Ϸ4 to 40 nmol/L. Lipid loading was achieved on days 8 through 10 during a 48-hour incubation with 50 g/mL of acetylated LDL in medium containing 10% (vol/vol) lipoprotein-deficient human serum (dϾ1.25). Cell viability for each treatment condition was 90% to 95%. LDL was isolated from plasma from healthy, normolipidemic subjects, and macrophage cell extracts were analyzed by high-performance liquid chromatography according to previously described methods. 9 
RNA Extraction and Measurement of AR mRNA Levels
After 7 to 8 days of culture in RPMI supplemented with postmenopausal serum, male-and female-donor MDMs were assessed for AR message.
Total RNA was extracted from each male-and female-donor experiment (1.5ϫ10 6 macrophages per well), and RNA was quantified with the SYBR Green II assay (Molecular Probes). 10 Androgen and ␤-actin (control) primers were designed from the published sequence of the human genes 11, 12 : AR (sense), 5Ј-AGATGGGCTTGACTTTCCCAGAAAG-3Ј; AR (antisense), 5Ј-ATGGCTGTCATTCAGTACTCCTGGA-3Ј.
Competition-based quantitative RT-PCR was performed with an AR competitor template as described elsewhere. 12 
Statistical Analysis
AR mRNA values are expressed as meanϮSEM. Statistical significance was analyzed with Fisher's exact test. Lipid-loading results are also expressed as meanϮSEM of at least triplicate wells per experiment per condition for each male and female donor. Results for each condition in each donor were calculated as a percentage of the control values (100%). Statistical significance by an independent-samples t test, Fischer's exact test where nՅ6, or a 1-way ANOVA for trend, as appropriate, was inferred at a 2-sided value of PϽ0.05.
Results
AR Expression in MDMs
Male-donor MDMs (nϭ8) expressed levels of AR mRNA Ͼ4 times greater than those isolated from premenopausal femaledonor cells (nϭ8) (0.64Ϯ0.06 versus 0.15Ϯ0.02 amol/g total RNA; PϽ0.001). This was evident on semiquantitative RT-PCR ( Figure 1A) , in which representative male samples showed distinct AR bands (545 bp), whereas the female samples showed less visible bands under the same conditions, and was confirmed by quantitative competition-based RT-PCR. AR mRNA levels were also low in cells from 3 postmenopausal females (0.18, 0.24, and 0.26 amol/g RNA, respectively, PϽ0.001, versus male levels, Pϭ0.16 versus premenopausal female levels) ( Figure 1B) .
Effects of Androgen Exposure on Macrophage Lipid Loading
The functional effects of this sex difference in AR expression were then explored. Androgen exposure was associated with a dose-dependent increase in intracellular CE content in male-donor MDMs (nϭ9) (CE as a percentage of control, 109Ϯ10%, 117Ϯ3%, and 120Ϯ4% for DHT 4, 40, and 400 nmol/L, respectively; Pϭ0.002 by ANOVA; Figure 2 ). This androgen-associated increase in CE accumulation was abrogated by coincubation with the nonsteroidal AR antagonist HF (CE content 95Ϯ8% for DHT 40 nmol/L and HF 400 nmol/L versus controls, Pϭ0.58). HF 400 nmol/L alone did not alter CE content significantly (110Ϯ7%, Pϭ0.1). Free cholesterol (FC) content in male-donor macrophages was not altered significantly by androgen exposure (Pϭ0.40). Absolute lipid-loading values in macrophages from 1 male donor (but comparable in nature to the others) were as follows: for control cells, CE 62Ϯ4 nmol/mg cell protein, FC 139Ϯ16 nmol/mg; and for DHT 40 nmol/L-treated cells, CE 78Ϯ2 nmol/mg cell protein, FC 132Ϯ11 nmol/mg cell protein.
In contrast to the male-donor cells, CE content in femaledonor macrophages (nϭ4) did not increase with androgen exposure (CE 86Ϯ11% and 75Ϯ15% for DHT 40 nmol/L and 
Discussion
Although the male predisposition to atherosclerosis is well documented, there are few studies assessing the effects of androgens on atherogenic processes. In this study, we have demonstrated a marked sex difference in the AR mRNA status of mature MDMs from healthy human subjects. Because MDMs play a key role in the early development of atherosclerosis, 6, 9 with macrophage lipid uptake leading to foam cell and fatty streak formation, we postulated that a greater expression of AR in these cells might contribute to the male predisposition to atherosclerosis. Indeed, our data indicate that the androgen dihydrotestosterone caused a doserelated and receptor-mediated increase in human macrophage lipid accumulation in male-but not female-donor cells. This is probably due to higher levels of AR in the male MDMs; however, it is possible that androgens may also influence lipoprotein metabolism via other pathways.
Sex differences have previously been documented in the levels of AR message found in macrophage-like synoviocytes, 13 and in rat aortic smooth muscle cells, 14 androgenreceptor protein levels are higher in male than in female animals. In these experimental studies, however, no functional correlates of these observations were investigated. In this first study of AR expression in human MDMs, the observed sex difference in AR message was associated with enhanced lipid loading by male-but not female-donor cells, consistent with a proatherogenic effect.
Dihydrotestosterone was used in these experiments because it is a potent, nonaromatizable physiological androgen that is specific for the AR. This avoids the potentially confounding effects of estrogenic metabolites that arise from the aromatization of testosterone, 15 noting that estrogens may also influence macrophage lipid loading. 9 An acetylated form of LDL was used in these experiments, because acetylated LDL is the standard type of modified LDL used in lipoprotein uptake experiments and a specific ligand for the scavenger receptor, which may play a critical role in foam cell formation (although additional pathways of modified LDL uptake also occur in vivo). 16 In summary, the androgen dihydrotestosterone increases CE accumulation in MDMs from male but not female subjects. Because this effect is receptor-mediated, the most likely reason for its sex specificity relates to the significantly higher levels of AR mRNA found in male-than in female-donor macrophages. These data are consistent with a significant effect of androgen exposure on foam cell formation in men. 
